Dynamic Contrast-Enhanced MR Imaging in the Evaluation of Patients with Prostate Cancer

Colm J. McMahon, B. Nicolas Bloch, Robert E. Lenkinski, Neil M. Rofsky

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Prostate cancer is a common tumor among men, with increasing diagnosis at an earlier stage and a lower volume of disease because of screening with prostate-specific antigen (PSA). The need for imaging of the prostate stems from a desire to optimize treatment strategy on a patient and tumor-specific level. The major goals of prostate imaging are (1) staging of known cancer, (2) determination of tumor aggressiveness, (3) diagnosis of cancer in patients who have elevated PSA but a negative biopsy, (4) treatment planning, and (5) the evaluation of therapy response. This article concentrates on the role of dynamic contrast-enhanced MR imaging in the evaluation of patients who have prostate cancer and how it might be used to help achieve the above goals. Various dynamic contrast enhancement approaches (quantitative/semiquantitative/qualitative, high temporal versus high spatial resolution) are summarized with reference to the relevant strengths and compromises of each approach.

Original languageEnglish (US)
Pages (from-to)363-383
Number of pages21
JournalMagnetic Resonance Imaging Clinics of North America
Volume17
Issue number2
DOIs
StatePublished - May 2009

Fingerprint

Prostatic Neoplasms
Prostate-Specific Antigen
Prostate
Neoplasms
Neoplasm Staging
Therapeutics
Biopsy

Keywords

  • Contrast media
  • Gadolinium-DTPA
  • Kinetics
  • MR imaging
  • Neoplasm staging
  • Prostatic neoplasm

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Dynamic Contrast-Enhanced MR Imaging in the Evaluation of Patients with Prostate Cancer. / McMahon, Colm J.; Bloch, B. Nicolas; Lenkinski, Robert E.; Rofsky, Neil M.

In: Magnetic Resonance Imaging Clinics of North America, Vol. 17, No. 2, 05.2009, p. 363-383.

Research output: Contribution to journalArticle

@article{53d2dc6fb194414a95d6a8ea03541d74,
title = "Dynamic Contrast-Enhanced MR Imaging in the Evaluation of Patients with Prostate Cancer",
abstract = "Prostate cancer is a common tumor among men, with increasing diagnosis at an earlier stage and a lower volume of disease because of screening with prostate-specific antigen (PSA). The need for imaging of the prostate stems from a desire to optimize treatment strategy on a patient and tumor-specific level. The major goals of prostate imaging are (1) staging of known cancer, (2) determination of tumor aggressiveness, (3) diagnosis of cancer in patients who have elevated PSA but a negative biopsy, (4) treatment planning, and (5) the evaluation of therapy response. This article concentrates on the role of dynamic contrast-enhanced MR imaging in the evaluation of patients who have prostate cancer and how it might be used to help achieve the above goals. Various dynamic contrast enhancement approaches (quantitative/semiquantitative/qualitative, high temporal versus high spatial resolution) are summarized with reference to the relevant strengths and compromises of each approach.",
keywords = "Contrast media, Gadolinium-DTPA, Kinetics, MR imaging, Neoplasm staging, Prostatic neoplasm",
author = "McMahon, {Colm J.} and Bloch, {B. Nicolas} and Lenkinski, {Robert E.} and Rofsky, {Neil M.}",
year = "2009",
month = "5",
doi = "10.1016/j.mric.2009.01.013",
language = "English (US)",
volume = "17",
pages = "363--383",
journal = "Magnetic Resonance Imaging Clinics of North America",
issn = "1064-9689",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Dynamic Contrast-Enhanced MR Imaging in the Evaluation of Patients with Prostate Cancer

AU - McMahon, Colm J.

AU - Bloch, B. Nicolas

AU - Lenkinski, Robert E.

AU - Rofsky, Neil M.

PY - 2009/5

Y1 - 2009/5

N2 - Prostate cancer is a common tumor among men, with increasing diagnosis at an earlier stage and a lower volume of disease because of screening with prostate-specific antigen (PSA). The need for imaging of the prostate stems from a desire to optimize treatment strategy on a patient and tumor-specific level. The major goals of prostate imaging are (1) staging of known cancer, (2) determination of tumor aggressiveness, (3) diagnosis of cancer in patients who have elevated PSA but a negative biopsy, (4) treatment planning, and (5) the evaluation of therapy response. This article concentrates on the role of dynamic contrast-enhanced MR imaging in the evaluation of patients who have prostate cancer and how it might be used to help achieve the above goals. Various dynamic contrast enhancement approaches (quantitative/semiquantitative/qualitative, high temporal versus high spatial resolution) are summarized with reference to the relevant strengths and compromises of each approach.

AB - Prostate cancer is a common tumor among men, with increasing diagnosis at an earlier stage and a lower volume of disease because of screening with prostate-specific antigen (PSA). The need for imaging of the prostate stems from a desire to optimize treatment strategy on a patient and tumor-specific level. The major goals of prostate imaging are (1) staging of known cancer, (2) determination of tumor aggressiveness, (3) diagnosis of cancer in patients who have elevated PSA but a negative biopsy, (4) treatment planning, and (5) the evaluation of therapy response. This article concentrates on the role of dynamic contrast-enhanced MR imaging in the evaluation of patients who have prostate cancer and how it might be used to help achieve the above goals. Various dynamic contrast enhancement approaches (quantitative/semiquantitative/qualitative, high temporal versus high spatial resolution) are summarized with reference to the relevant strengths and compromises of each approach.

KW - Contrast media

KW - Gadolinium-DTPA

KW - Kinetics

KW - MR imaging

KW - Neoplasm staging

KW - Prostatic neoplasm

UR - http://www.scopus.com/inward/record.url?scp=65249093663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249093663&partnerID=8YFLogxK

U2 - 10.1016/j.mric.2009.01.013

DO - 10.1016/j.mric.2009.01.013

M3 - Article

VL - 17

SP - 363

EP - 383

JO - Magnetic Resonance Imaging Clinics of North America

JF - Magnetic Resonance Imaging Clinics of North America

SN - 1064-9689

IS - 2

ER -